Universe Pharmaceuticals (UPC) Equity Average (2021 - 2025)
Historic Equity Average for Universe Pharmaceuticals (UPC) over the last 5 years, with Q3 2025 value amounting to $50816.2 billion.
- Universe Pharmaceuticals' Equity Average rose 12335.35% to $50816.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $50816.2 billion, marking a year-over-year increase of 12335.35%. This contributed to the annual value of $50816.2 billion for FY2025, which is 12321.64% up from last year.
- Universe Pharmaceuticals' Equity Average amounted to $50816.2 billion in Q3 2025, which was up 12335.35% from $22751.5 billion recorded in Q3 2024.
- Universe Pharmaceuticals' Equity Average's 5-year high stood at $50816.2 billion during Q3 2025, with a 5-year trough of $33.9 million in Q3 2021.
- In the last 5 years, Universe Pharmaceuticals' Equity Average had a median value of $15.8 billion in 2023 and averaged $9203.9 billion.
- Within the past 5 years, the most significant YoY rise in Universe Pharmaceuticals' Equity Average was 16231037.06% (2024), while the steepest drop was 2086.28% (2024).
- Quarter analysis of 5 years shows Universe Pharmaceuticals' Equity Average stood at $33.9 million in 2021, then soared by 52103.81% to $17.7 billion in 2022, then dropped by 20.84% to $14.0 billion in 2023, then soared by 162310.37% to $22751.5 billion in 2024, then skyrocketed by 123.35% to $50816.2 billion in 2025.
- Its Equity Average stands at $50816.2 billion for Q3 2025, versus $22751.5 billion for Q3 2024 and $14.0 billion for Q1 2024.